Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study. [electronic resource]
Producer: 20130624Description: 573-8 p. digitalISSN:- 1095-6859
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab
- Carboplatin -- administration & dosage
- Disease-Free Survival
- Female
- Humans
- Maintenance Chemotherapy
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Placebos
- Quality of Life
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.